GLMD logo

Galmed Pharmaceuticals (GLMD) Total Liabilities

Annual Total Liabilities

$2.75 M
-$388.00 K-12.36%

31 December 2023

GLMD Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$2.51 M
+$960.00 K+61.78%

30 September 2024

GLMD Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GLMD Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.4%+20.2%
3 y3 years-66.6%-62.0%
5 y5 years+1.6%-36.0%

GLMD Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-66.6%at low-62.0%+61.8%
5 y5 years-66.6%+1.6%-69.5%+61.8%
alltimeall time-66.6%+81.2%-69.5%+121.3%

Galmed Pharmaceuticals Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$2.51 M(+61.8%)
June 2024
-
$1.55 M(-12.0%)
Mar 2024
-
$1.76 M(-35.8%)
Dec 2023
$2.75 M(-12.4%)
$2.75 M(+31.5%)
Sept 2023
-
$2.09 M(-23.2%)
June 2023
-
$2.72 M(-2.8%)
Mar 2023
-
$2.80 M(-10.7%)
Dec 2022
$3.14 M(-48.6%)
$3.14 M(-38.7%)
Sept 2022
-
$5.12 M(+78.8%)
June 2022
-
$2.86 M(-50.9%)
Mar 2022
-
$5.83 M(-4.6%)
Dec 2021
$6.11 M(-25.8%)
$6.11 M(-7.8%)
Sept 2021
-
$6.62 M(-9.6%)
June 2021
-
$7.33 M(-1.3%)
Mar 2021
-
$7.42 M(-9.8%)
Dec 2020
$8.23 M(+12.9%)
$8.23 M(+30.7%)
Sept 2020
-
$6.30 M(+26.8%)
June 2020
-
$4.96 M(-21.6%)
Mar 2020
-
$6.33 M(-13.1%)
Dec 2019
$7.29 M
$7.29 M(+85.4%)
Sept 2019
-
$3.93 M(+5.5%)
June 2019
-
$3.72 M(+28.1%)
DateAnnualQuarterly
Mar 2019
-
$2.91 M(+7.5%)
Dec 2018
$2.71 M(-29.7%)
$2.71 M(+26.5%)
Sept 2018
-
$2.14 M(-43.8%)
June 2018
-
$3.80 M(+41.0%)
Mar 2018
-
$2.70 M(-29.9%)
Dec 2017
$3.85 M(-28.4%)
$3.85 M(+22.4%)
Sept 2017
-
$3.15 M(-16.9%)
June 2017
-
$3.79 M(-13.1%)
Mar 2017
-
$4.36 M(-19.0%)
Dec 2016
$5.38 M(+97.8%)
$5.38 M(+36.6%)
Sept 2016
-
$3.93 M(+10.0%)
June 2016
-
$3.58 M(+11.7%)
Mar 2016
-
$3.20 M(+17.8%)
Dec 2015
$2.72 M(+79.1%)
$2.72 M(+79.6%)
Sept 2015
-
$1.51 M(-10.7%)
June 2015
-
$1.70 M(+8.6%)
Mar 2015
-
$1.56 M(+2.8%)
Dec 2014
$1.52 M(-28.3%)
$1.52 M(-48.2%)
Sept 2014
-
$2.93 M(+158.2%)
June 2014
-
$1.14 M(-41.1%)
Mar 2014
-
$1.93 M(-8.9%)
Dec 2013
$2.12 M(-22.8%)
$2.12 M
Dec 2012
$2.74 M
-

FAQ

  • What is Galmed Pharmaceuticals annual total liabilities?
  • What is the all time high annual total liabilities for Galmed Pharmaceuticals?
  • What is Galmed Pharmaceuticals annual total liabilities year-on-year change?
  • What is Galmed Pharmaceuticals quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Galmed Pharmaceuticals?
  • What is Galmed Pharmaceuticals quarterly total liabilities year-on-year change?

What is Galmed Pharmaceuticals annual total liabilities?

The current annual total liabilities of GLMD is $2.75 M

What is the all time high annual total liabilities for Galmed Pharmaceuticals?

Galmed Pharmaceuticals all-time high annual total liabilities is $8.23 M

What is Galmed Pharmaceuticals annual total liabilities year-on-year change?

Over the past year, GLMD annual total liabilities has changed by -$388.00 K (-12.36%)

What is Galmed Pharmaceuticals quarterly total liabilities?

The current quarterly total liabilities of GLMD is $2.51 M

What is the all time high quarterly total liabilities for Galmed Pharmaceuticals?

Galmed Pharmaceuticals all-time high quarterly total liabilities is $8.23 M

What is Galmed Pharmaceuticals quarterly total liabilities year-on-year change?

Over the past year, GLMD quarterly total liabilities has changed by +$423.00 K (+20.23%)